HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Afsar Rahbar Selected Research

Valganciclovir

4/2022Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma.
9/2020Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma.
1/2020Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients.
7/2014Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.
9/2013Survival in patients with glioblastoma receiving valganciclovir.
9/2013Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
10/2011Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Afsar Rahbar Research Topics

Disease

20Infections
11/2021 - 05/2003
20Neoplasms (Cancer)
01/2021 - 10/2011
15Glioblastoma (Glioblastoma Multiforme)
04/2022 - 04/2009
6Breast Neoplasms (Breast Cancer)
05/2021 - 01/2013
5Cytomegalovirus Infections (Inclusion Disease)
11/2021 - 05/2003
4Carcinogenesis
08/2019 - 04/2009
3Ovarian Neoplasms (Ovarian Cancer)
02/2020 - 01/2018
3Medulloblastoma
01/2020 - 10/2011
3Cardiovascular Diseases (Cardiovascular Disease)
12/2015 - 01/2008
2Atherosclerosis
05/2021 - 05/2021
2Rheumatoid Arthritis
05/2021 - 01/2014
2Cholestasis
01/2021 - 01/2017
2Glioma (Gliomas)
01/2018 - 04/2009
2Inflammation (Inflammations)
01/2017 - 06/2011
2Brain Neoplasms (Brain Tumor)
11/2016 - 12/2014
2Colonic Neoplasms (Colon Cancer)
12/2014 - 06/2012
2Atherosclerotic Plaque (Atheroma)
03/2014 - 11/2013
2Acquired Immunodeficiency Syndrome (AIDS)
01/2008 - 05/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2008 - 05/2003
1Pulmonary Hypertension
11/2021
1Necrotizing Enterocolitis
01/2021
1Disease Progression
09/2020
1Genomic Instability
01/2020
1Triple Negative Breast Neoplasms
11/2019
1Cystadenoma
12/2018
1Carcinoma (Carcinomatosis)
01/2018
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2017
1Viremia
01/2017
1Chronic Kidney Failure (Chronic Renal Failure)
01/2017
1Hypoxia (Hypoxemia)
08/2014
1Anemia
08/2014
1Diabetes Mellitus
01/2014
1Neuroblastoma
11/2013
1Neoplasm Metastasis (Metastasis)
01/2013

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2008
13DNA (Deoxyribonucleic Acid)IBA
01/2021 - 05/2003
8AntigensIBA
11/2017 - 05/2003
7ValganciclovirFDA Link
04/2022 - 10/2011
6ParaffinIBA
05/2021 - 01/2013
5Antiviral Agents (Antivirals)IBA
04/2022 - 10/2011
5Immunoglobulin G (IgG)IBA
05/2021 - 02/2008
4Messenger RNA (mRNA)IBA
05/2021 - 01/2008
4Nucleic AcidsIBA
05/2019 - 01/2013
3Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2021 - 01/2008
3Pharmaceutical PreparationsIBA
09/2020 - 11/2019
3RNA (Ribonucleic Acid)IBA
11/2017 - 10/2011
2Endothelin Receptor AntagonistsIBA
11/2021 - 01/2018
2Endothelin Receptors (Endothelin Receptor)IBA
11/2021 - 12/2015
2Prolactin Receptors (Prolactin Receptor)IBA
02/2020 - 11/2016
2MethyltransferasesIBA
04/2018 - 06/2012
2Azacitidine (5 Azacytidine)FDA Link
04/2018 - 06/2012
2Progesterone Receptors (Progesterone Receptor)IBA
11/2017 - 01/2013
2thiamine triphosphorate (TTP)IBA
02/2016 - 05/2013
1BQ 788IBA
11/2021
1ambrisentanFDA Link
11/2021
1macitentanIBA
11/2021
1aprocitentanIBA
11/2021
1Bosentan (Tracleer)FDA Link
11/2021
1letermovirIBA
11/2021
1Ganciclovir (Cytovene)FDA LinkGeneric
11/2021
1AntibodiesIBA
05/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2020
1Biomarkers (Surrogate Marker)IBA
02/2020
1ProlactinIBA
02/2020
1Bovine Serum AlbuminIBA
01/2020
1Replication Protein AIBA
01/2020
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2020
1Growth Factor ReceptorsIBA
01/2020
1Phosphates (Orthophosphate)IBA
01/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2019
1Immunoglobulin M (IgM)IBA
12/2018
1Single-Domain AntibodiesIBA
01/2018
1Endothelin B ReceptorIBA
01/2018
1ChemokinesIBA
01/2018
1Chemokine ReceptorsIBA
01/2018
1Hormones (Hormone)IBA
11/2017
1Estrogen ReceptorsIBA
11/2017
1AutoantibodiesIBA
01/2017
1Endothelin-1 (Endothelin 1)IBA
12/2015
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2015
1Vasoconstrictor AgentsIBA
12/2015
1Oxygen (Dioxygen)IBA
08/2014
1ErythropoietinFDA Link
08/2014
1Transcription Factors (Transcription Factor)IBA
08/2014
1ArginaseIBA
03/2014
1Connexin 43 (Connexin43)IBA
01/2014
1human cytomegalovirus microRNA-UL112IBA
01/2014
1Tissue ExtractsIBA
11/2013
1Formaldehyde (Formol)FDA Link
01/2013
1Estrogen Receptor alphaIBA
01/2013
1Dinoprostone (PGE2)FDA Link
10/2011
1Immediate-Early ProteinsIBA
10/2011

Therapy/Procedure

6Therapeutics
04/2022 - 09/2013
3Kidney Transplantation
01/2017 - 10/2013
1Parenteral Nutrition
01/2021
1Immunotherapy
11/2019
1Neoadjuvant Therapy
01/2018
1Carotid Endarterectomy
11/2013
1Drug Therapy (Chemotherapy)
05/2013
1Adjuvant Radiotherapy
05/2013